LYMPHOMA, LARGE B-CELL, DIFFUSE
Clinical trials for LYMPHOMA, LARGE B-CELL, DIFFUSE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, LARGE B-CELL, DIFFUSE trials appear
Sign up with your email to follow new studies for LYMPHOMA, LARGE B-CELL, DIFFUSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Chemo-Light combo offers hope for older lymphoma patients
Disease control OngoingThis study tests a new drug combination (rituximab, polatuzumab vedotin, and glofitamab) for people over 60 with aggressive B-cell lymphoma who cannot tolerate full-dose chemotherapy. The goal is to see if this lighter treatment can control the disease and improve survival. 125 p…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Promising new combo therapy targets rare brain cancer
Disease control OngoingThis study tests adding either lenalidomide or ibrutinib to standard chemotherapy for adults aged 18-65 with newly diagnosed primary central nervous system lymphoma (a rare brain cancer). The goal is to improve treatment response before a stem cell transplant. The trial first fin…
Matched conditions: LYMPHOMA, LARGE B-CELL, DIFFUSE
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 12, 2026 13:42 UTC